Literature DB >> 4259829

The effect of bacterial products on synovial fibroblast function: hypermetabolic changes induced by endotoxin.

R B Buckingham, C W Castor.   

Abstract

The effects of bacterial products on selected synovial fibroblast functions were studied. Extracts of commonly encountered microorganisms were prepared by sonic or mechanical disruption. "Purified" endotoxins were prepared from selected organisms, and in some cases were purchased commercially. Normal fibroblasts were derived from synovial connective tissue obtained from amputations or arthrotomy. The cells were grown as a monolayer on glass and were nourished by a semisynthetic nutrient medium. Extracts of Gram-negative bacteria, applied to fibroblast cultures, markedly increased hyaluronic acid production, glucose utilization, and lactate output. Treatment of the extracts with heat at 100 degrees C for (1/2) hr decreased their effectiveness by approximately 40%. Purified Gram-negative bacterial endotoxin stimulated synovial fibroblasts to an extent comparable to that caused by heat-treated whole extracts. The lipid moiety of the endotoxin molecule appeared to account for much of the stimulatory activity of the endotoxin. Extracts of commonly encountered Gram-positive cocci, yeast, and Mycoplasma had no stimulating capabilities. Corynebacterial extracts, however, had definite stimulating potential. Endotoxin-synovial cell interaction experiments demonstrated that endotoxin was bound to fibroblasts. Reassay of the endotoxin after extraction from the cells showed that it retained its stimulatory potential. The metabolic phenomena stimulated by bacterial products duplicate the major known actions of connective tissue-activating peptide (CTAP). The observations made in this study suggest that bacterial products may participate in a fundamental way in the activation process, and indicate a possible role for bacterial products in synovial inflammation in humans.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4259829      PMCID: PMC292249          DOI: 10.1172/JCI106912

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Isolation of diphtheroid organisms from rheumatoid synovial membrane and fluid.

Authors:  J J Duthie; S M Stewart; W R Alexander; R E Dayhoff
Journal:  Lancet       Date:  1967-01-21       Impact factor: 79.321

2.  Immunopathological studies on experimental arthritis-lesions in synovial tissue during endotoxemia.

Authors:  S Aoki; K Ikuta
Journal:  Bull Osaka Med Sch       Date:  1968-10

3.  Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation.

Authors:  C W Castor; R K Prince; M J Hazelton
Journal:  Arthritis Rheum       Date:  1966-12

4.  Effects of rheumatoid sera on fibroblast proliferation and hyaluronic acid synthesis.

Authors:  C W Castor; D Wright; R B Buckingham
Journal:  Arthritis Rheum       Date:  1968-10

5.  The role of infection in the causation of rheumatoid arthritis.

Authors:  A G Hill
Journal:  Proc R Soc Med       Date:  1968-10

6.  Relation of structure to function in bacterial O-antigens. V. Nature of active sites in endotoxic lipopolysaccharides of Serratia marcescens.

Authors:  D Tripodi; A Nowotny
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

7.  Leukocyte-connective tissue cell interaction. I. Stimulation of hyaluronate synthesis by live and dead leukocytes.

Authors:  M Yaron; C W Castor
Journal:  Arthritis Rheum       Date:  1969-08

8.  Synovial cell synthesis of a substance immunologically like cartilage proteinpolysaccharide.

Authors:  R Janis; J Sandson; C Smith; D Hamerman
Journal:  Science       Date:  1967-12-15       Impact factor: 47.728

9.  Abnormalities of connective tissue cells cultured from patients with rheumatoid arthritis. I. Relative unresponsiveness of rheumatoid synovial cells to hydrocortisone.

Authors:  C W Castor; E L Dorstewitz
Journal:  J Lab Clin Med       Date:  1966-08

10.  Synovial inflammatory response to bacterial endotoxin.

Authors:  J W Hollingsworth; E Atkins
Journal:  Yale J Biol Med       Date:  1965-12
View more
  10 in total

1.  Persistence of E. coli O- and K-antigens in experimental pyelonephritis.

Authors:  K F Klippel; W Sietzen; W Hauk
Journal:  Urol Res       Date:  1973-10

2.  Stimulation of macromolecular synthesis by endotoxin-treated 3T6 fibroblasts.

Authors:  J J Aleo
Journal:  Experientia       Date:  1980-05-15

3.  Rapid diagnosis of septic arthritis by quantitative analysis of joint fluid lactic acid with a monotest lactate kit.

Authors:  I Brook; G Controni
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

4.  The biology of the rheumatoid synovial cell.

Authors:  D M Haselwood; J J Castles
Journal:  West J Med       Date:  1977-09

5.  Interaction between endotoxin and human monocytes: characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance.

Authors:  N E Larsen; R Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Effect of lipopolysaccharide on proteoglycan synthesis by adult human gingival fibroblasts in vitro.

Authors:  P M Bartold; S J Millar
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

7.  New phenotypic marker for lipopolysaccharide responsiveness.

Authors:  S V Gollapudi; S H Gregory; M Kern
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

8.  Bacterial lipopolysaccharides induce in vitro degradation of cartilage matrix through chondrocyte activation.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

9.  Lactate UV-system: a rapid method for diagnosis of septic arthritis.

Authors:  A R Behn; J A Mathews; I Phillips
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

Review 10.  Synovial fibroblasts in 2017.

Authors:  Caroline Ospelt
Journal:  RMD Open       Date:  2017-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.